MUMBAI, India, July 5 -- Intellectual Property India has published a patent application (202311041742 A) filed by Akums Drugs & Pharmaceuticals Limited, New Delhi, on Dec. 19, 2023, for 'a solid oral composition comprising of sustained release dydrogesterone and progesterone.'
Inventor(s) include Jain Sanjeev.
The application for the patent was published on July 4, under issue no. 27/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to an oral composition comprising fixed dose combination of Dydrogesterone and Progesterone in a single unit dosage form wherein oral composition is a solid unit dosage form. The composition of the present invention is a novel drug delivery system which avoid drawbacks associated with current prescribed regimen and dosage form. The oral composition provides sustained release of active agents thereby reducing dose frequency, side effects and is more patient compliant."
Disclaimer: Curated by HT Syndication.
